
PureTech’s Akili Achieves Primary Endpoint in Pivotal Study of Investigational Digital Medicine for Paediatric ADHD
In a randomised, controlled trial of 348 children and adolescents diagnosed with ADHD, AKL-T01 showed a statistically significant improvement compared to an active control (p=0.006) on the predefined primary endpoint, a change in the Attention […]